Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Clinical trial NCT07569926 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07569926
- Sponsor
- Blue Earth Diagnostics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-12-31
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.